<DOC>
	<DOCNO>NCT00005316</DOCNO>
	<brief_summary>To investigate mechanism white coat hypertension study risk factor heart damage .</brief_summary>
	<brief_title>White Coat Hypertension Antihypertensive Treatment Effect - SCOR Hypertension</brief_title>
	<detailed_description>BACKGROUND : The multidisciplinary SCOR examine cause , consequence , treatment human hypertension . A central theme renal basis human hypertension . The subproject white coat hypertension begin December 1985 . DESIGN NARRATIVE : In longitudinal study , eighty patient white coat hypertension compare 40 age- sex-matched normotensives , 80 patient sustained hypertension . The protocol consist ( ) clinic blood pressure measurement make physician nurse , ( b ) self-monitoring home , ( c ) noninvasive ambulatory monitoring , ( ) reactivity test ( cold pressor test , mental arithmetic , isometric exercise ) ( e ) Korotkoff signal recording . Patients also test early marker disease ( echocardiography urine albumin ) . The 80 patient two hypertensive group randomize one four treatment protocol ( 20 patient ) ; alpha blocker , beta blocker , combine alpha- beta-blocker , ACE inhibitor . The dos medication adjust produce similar reduction clinic blood pressure different group . The test battery ( a-e ) report treatment . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>White Coat Hypertension</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2001</verification_date>
</DOC>